Cargando…
Simulations of Promising Indolizidine—α6-β2 Nicotinic Acetylcholine Receptor Complexes
Smoking-cessation drugs bind many off-target nicotinic acetylcholine receptors (nAChRs) and cause severe side effects if they are based on nicotine. New drugs that bind only those receptors, such as [Formula: see text] 6 [Formula: see text] 2* nAChR, implicated in nicotine addiction would avoid the...
Autores principales: | Acquah, Francis A., Paramel, Matthew, Kuta, Adama, Hussaini, Syed R., Wallace, David R., Mooers, Blaine H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347036/ https://www.ncbi.nlm.nih.gov/pubmed/34360698 http://dx.doi.org/10.3390/ijms22157934 |
Ejemplares similares
-
Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation
por: Singh, J., et al.
Publicado: (2008) -
Targeting RNA Structure to Inhibit Editing in Trypanosomes
por: Acquah, Francis A., et al.
Publicado: (2023) -
Coupling of acceptor-substituted diazo compounds and tertiary thioamides: synthesis of enamino carbonyl compounds and their pharmacological evaluation
por: Secka, Jim, et al.
Publicado: (2022) -
Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs
por: Klochkov, Sergey, et al.
Publicado: (2021) -
Total synthesis of the indolizidine alkaloid tashiromine
por: Marsden, Stephen P, et al.
Publicado: (2008)